Showing results (2151-2160 of 2,418) with videos related to

Sort By:
Pageof 242
Clinical Oral Implants Research|August 22, 2025
Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical TrialMariano Sanz, Cecilie Gjerde, Bjørn Tore Gjertsen, et al.
Scientific Reports|April 15, 2024
Prevalence of pulmonary tuberculosis and HIV infections and risk factors associated to tuberculosis in detained persons in Antananarivo, MadagascarFanjasoa Rakotomanana, Anou Dreyfus, Mirella M Randrianarisoa, et al.
Leukemia|February 5, 2021
Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMTJordi Esteve, Sebastian Giebel, Myriam Labopin, et al.
Transplantation and Cellular Therapy|August 28, 2022
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Haematologica|April 9, 2016
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working PartyRaynier Devillier, Jean-Hugues Dalle, Austin Kulasekararaj, et al.
Leukemia|December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity mattersPeter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
Bone Marrow Transplantation|February 17, 2019
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)Amandine Fayard, Elisabeth Daguenet, Didier Blaise, et al.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
Pageof 242